Influenza & Coronavirus Pandemic Preparedness Asia 2013
Conference - Singapore
The mortality rate from the MER-CoV virus has now hit 60%, with 30 deaths to date across the Middle East and now spreading to France, Britain and Germany (as at 1 June 2013).
Not only has this virus been in the news, but also the recent occurrence of H7N9, which has had 130 confirmed cases to date (as at 1 June 2013).
Most countries are armed with more experience to deal with such outbreaks than 10 years ago when there was the SARs outbreak. However, issues of rapid development and deployment of vaccines/drugs and efficient disease surveillance and control remain significant.
Hampered by insufficient understanding of the new viruses, efficient and effective contingency planning is in particular important to containing the spread of a new disease.
IBC Asia’s Pandemic Preparedness Asia 2013 Conference brings together international and regional experts in one platform to review strategies and best practices to deal with a potential pandemic.
In addition, issues with establishing sustainable public-private partnerships to effectively address the looming threats of novel viruses will be critically examined.
Organization: IBC Asia (S) Pte Ltd
(Courtesy of Influenza & Coronavirus Pandemic Preparedness Asia 2013 logo, via ibc-asia.com)
Influenza & Coronavirus Pandemic Preparedness Asia 2013
Wed, Oct 23, 2013 - Thu, Oct 24, 2013
Traders Hotel Singapore, Singapore
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
